“…Skeletal CASQ1 pathological missense mutations in heterozygous conditions are linked to either malignant hyperthermia (CASQ1 M87T) or tubular aggregate myopathy (CASQ1 D44N, G103D, D244G, I387T) [15,83,84], whereas the numerous pathological mutations of the cardiac isoform lead to Catecholaminergic Polymorphic Ventricular Tachycardia type 2 (CPVT2) mainly in homozygosis [31,36,85]. CASQ1 and CASQ2 missense mutations are scattered across all three thioredoxin domains of CASQ and the mutated proteins do not share any common defect in their Ca 2+ -dependent polymerization properties [31,36,85,86]. Moreover, most of the published biochemical analyses on either the polymerization and/or Ca 2+ -buffering capabilities of recombinant CASQ missense pathological mutants [15,28,31,[33][34][35][36][85][86][87][88][89][90] (Table 1) are sometimes difficult to interpret or in contrast with each other.…”